Cargando…
Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation
Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...
Autores principales: | Fujita, Kohei, Naka, Megumi, Ito, Takanori, Kanai, Osamu, Maekawa, Koichi, Nakatani, Koichi, Mio, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024693/ https://www.ncbi.nlm.nih.gov/pubmed/33854939 http://dx.doi.org/10.1016/j.rmcr.2021.101393 |
Ejemplares similares
-
Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
por: Kanai, Osamu, et al.
Publicado: (2016) -
Impact of COVID‐19 pandemic on lung cancer treatment scheduling
por: Fujita, Kohei, et al.
Publicado: (2020) -
Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014) -
Colonic Cast after Disseminated Intravascular Coagulation
por: Nagase, Koya, et al.
Publicado: (2021) -
Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation
por: Miyanaga, Akihiko, et al.
Publicado: (2013)